|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 38/22 | (2006.01) | ||
| A61B 5/00 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 9/04 | (2006.01) |
| (11) | Patento numeris | 3154559 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15730858.6 |
| Europos patento paraiškos padavimo data | 2015-06-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/054399 |
| Data | 2015-06-10 |
| (87) | Numeris | WO 2015/189790 |
| Data | 2015-12-17 |
| (30) | Numeris | Data | Šalis |
| 201462011744 P | 2014-06-13 | US |
| (72) |
PRESCOTT, Margaret Forney , US
ZHANG, Yiming , US
DAHLKE, Marion , CH
SEVERIN, Thomas , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF SERELAXIN TO REDUCE GDF-15 |
| USE OF SERELAXIN TO REDUCE GDF-15 |